Congressional appropriators face difficult decisions in a time of imposed national budget constraint. However, the move by the House Appropriations Committee to terminate the Agency for Healthcare Research and Quality (AHRQ) is the wrong way to address
Read More...
Read the complete post at http://healthaffairs.org/blog/2015/06/29/ahrq-and-the-essential-bothand-of-federal-investments-in-medical-discoveries/
Posted
Jun 29 2015, 10:54 AM
by
Health Affairs Blog
Filed under: Quality, Innovation, Featured, Organization and Delivery, Costs and Spending, AHRQ, House Appropriations Committee, health services research, National Institutes of Health, HSR, health policy research, Centers for Disease Control